With a deep-rooted understanding of pharmacology, toxicology, and ADME, I love bringing an holistic, translational approach to drug development, bridging the gap from bench to bedside to drive innovation in the pharmaceutical industry
YEARS OF IMPACT
Transforming Biotech into Opportunities
CAN:
Help transforming your biotech project into investor-ready and partner-attractive ventures by accelerating drug discovery and development with substantial 35 years experience in pre-regulatory and regulatory research development to progress projects with short resources.
HOW:
Hands-on support with regulatory insight
Investor and partner readiness
Access to a network of experts, CROs, and KOLs
TO:
Differentiate your project — make it stand out in a crowded market
Accelerate development — move smarter and faster through key milestones
Prepare for funding — get investor-ready with the right story and data
Advance to the next phase — from preclinical to clinical and beyond
Connect with biotech experts and strategic partners
Contact
+34 680 340 153
Gap & Strategic analysis on preclinical regulatory plan to support clinical, presentations for governance committees, investors and other relevant audiences